Serum erythropoietin levels in 696 patients investigated for erythrocytosis with <scp> <i>JAK2</i> </scp> mutation analysis-Reference-Cited by-同舟云学术

Serum erythropoietin levels in 696 patients investigated for erythrocytosis with JAK2 mutation analysis

Published:2022-01-26 Issue:4 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Chin‐Yee Benjamin¹²^ORCID,Cheong Ian³,Matyashin Maxim¹²,Lazo‐Langner Alejandro¹²,Chin‐Yee Ian¹²³,Bhayana Vipin³,Bhai Pratibha⁴⁵,Lin Hanxin³⁴,Sadikovic Bekim³⁴⁵^ORCID,Hsia Cyrus C.¹²

Affiliation:

1. Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry Western University London Ontario Canada

2. Division of Hematology, Department of Medicine London Health Sciences Centre London Ontario Canada

3. Department of Pathology and Laboratory Medicine, Schulich School of Medicine and Dentistry Western University London Ontario Canada

4. Molecular Diagnostic Division London Health Sciences Centre London Ontario Canada

5. Verspeeten Clinical Genome Centre London Health Sciences Centre London Ontario Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26471

Reference8 articles.

1. Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017

2. Laboratory Investigation of Myeloproliferative Neoplasms (MPNs)

3. Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

4. Investigation and management of erythrocytosis

5. How I treat polycythemia vera

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study;Journal of General Internal Medicine;2022-11-30

2. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level;Current Oncology;2022-09-30

3. High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia;Wiener klinische Wochenschrift;2022-04-07